Absolutely research for treatments which can save lives and treat the serious and most dire Covid 19 cases— will not only still be a Priority, but really is CRUCIAL., .. because this is a global ,and US especially, terrible disease pandemic !
Hospitals everywhere want to be able to save people’s lives where at present there is very little hope for acute Covid ARDS patients needing to go onto intubation .
MSCs are seen as being efficacious. The trials are vital and give a chance to save some people’s lives .
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-299
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |